Skip to content
Screener

Phibro Animal Health PAHC Animal Health — Revenue

Other segment segments

Mineral Nutrition
$73.42M+9.9%
Performance Products
$18.9M-16.6%

Similar metrics at other companies

Cencora logo
CORAnimal Health — Revenue
$1.52B+3.3%
Zoetis logo
ZTSAnimal health diagnostics — Revenue
$123M+11.8%
Leidos Holdings logo
LDOSHealth — Revenue
$1.19B0.0%
Omnicom Group logo
OMCHealth — Revenue
$586M+76.2%
Zoetis logo
ZTSCompanion Animal — Revenue
$1.71B-4.6%
Willis Towers Watson logo
WTWHealth Wealth And Career — Revenue
$1.29B+7.8%

Other financials

Income statement

See full
Revenue$383.5M+10.3%
Gross profit$125.7M+20.2%
Operating income$44.7M+33.2%
Net income$24.0M+15.1%
EPS (diluted)$0.59+15.7%

Balance sheet

See full
Cash & equivalents$54.9M-9.0%
Total debt$32.3M+27.8%
Total equity$361.8M+36.0%
Total assets$1.4B+9.7%

Cash flow

See full
Operating cash flow$16.2M-62.4%
CapEx$15.3M+97.7%
Free cash flow$890.0K-97.5%

Valuation

See full
Market cap$1.44B+20.2%
Enterprise value$1.42B+19.2%
P/E15.1×-9.7×
P/S0.0×

Profitability

See full
Gross margin32.5%+0.9pp
Operating margin12%+4.0pp
Net margin6.3%+3.7pp
FCF margin0.9%-3.3pp

Returns & leverage

See full
Return on equity30.3%+18.5pp
Debt / equity0.1×0.0×
Current ratio3.2×+0.3×

Where this comes from

Reported directly by Phibro Animal Health in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Phibro Animal Health’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:25 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056280
For the Periods Ended March 31Three Months / 2026Three Months / 2025Nine Months / 2026Nine Months / 2025
Animal Health
MFAs and other$205,789$181,645$603,098$439,827
Nutritional specialties46,81043,350145,191131,908
Vaccines38,62633,382116,36998,583
Total Animal Health$291,225$258,377$864,658$670,318
Mineral Nutrition73,41866,774205,351189,086
Performance Products18,90022,67451,33758,114
Total$383,543$347,825$1,121,346$917,518

Item 1. Financial Statements (unaudited)

FAQ

What is Phibro Animal Health's animal health — revenue?
Phibro Animal Health (PAHC) reported animal health — revenue of $291.23M in Q1 2026.
How has Phibro Animal Health's animal health — revenue changed year-over-year?
Phibro Animal Health's animal health — revenue increased by 12.7% year-over-year, from $258.38M to $291.23M.
What is the long-term trend for Phibro Animal Health's animal health — revenue?
Over 3 years (2022 to 2025), Phibro Animal Health's animal health — revenue has grown at a 16.6% compound annual growth rate (CAGR), from $607.06M to $962.8M.
What does animal health — revenue mean?
This metric represents the net revenue recognized from the sale of animal health products, such as antibacterials, vaccines, and nutritional specialties, to external customers. It is the core measure of the segment's ability to generate value from its primary business activities. Tracking this metric is essential for evaluating the segment's market share growth and competitive positioning within the animal health industry.

Ask your AI about Phibro Animal Health's animal health — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude